Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection

NCT04948528 is registered in ClinicalTrials.gov with AnchorDx Medical Co., Ltd. as lead sponsor.

NCT NCT04948528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04948528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection
Lead sponsor
AnchorDx Medical Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2020
Completion date
December 31, 2023
Enrollment
490 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

upper tract urothelial carcinoma